Latest acute leukemia Stories
Clinical Results Indicate that CX-01, Combined with Intensive Chemotherapy for Acute Leukemia, May Enhance Treatment Efficacy and Blood Count Recovery WESTON, Fla., June 1, 2015 /PRNewswire/
Data Presented at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting MENLO PARK, Calif., June 1, 2015 /PRNewswire/ -- Asterias Biotherapeutics, Inc.
- Results from Phase 1/2 trial investigating drug candidate for rare, aggressive blood cancer announced at American Society of Clinical Oncology annual meeting; Phase 3 trial planned for late 2015.
Study demonstrates improvement in key disease measurements and disease-related symptoms with pacritinib treatment compared to best available therapy, regardless of platelet levels at the time of enrollment
BEIJING, May 29, 2015 /PRNewswire/ -- According to Dr.
THOUSAND OAKS, Calif., May 27, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will present data from multiple Kyprolis(®) (carfilzomib) for Injection, BLINCYTO(®) (blinatumomab),
WESTON, Fla., May 18, 2015 /PRNewswire/ -- Cantex Pharmaceuticals, a clinical stage biopharmaceutical company developing medications
Data to be Featured in Oral Presentation at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting MENLO PARK, Calif., May 14, 2015 /PRNewswire/ -- Asterias Biotherapeutics,
SAN DIEGO AND TORONTO, May 5, 2015 /PRNewswire/ - Aptose Biosciences Inc.
- The parings of haberdine; also, any kind of fragments.